Opioid-Induced Constipation (OIC) Treatment Market Report

Global and Region Opioid-Induced Constipation (OIC) Treatment Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 03, 2022
  • PAGES：165
  • REPORT CODE：GMM1018889
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Opioid-Induced Constipation (OIC) Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Opioid-Induced Constipation (OIC) Treatmentmarket, defines the market attractiveness level of Opioid-Induced Constipation (OIC) Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Opioid-Induced Constipation (OIC) Treatment industry, describes the types of Opioid-Induced Constipation (OIC) Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Opioid-Induced Constipation (OIC) Treatment market and the development prospects and opportunities of Opioid-Induced Constipation (OIC) Treatment industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Opioid-Induced Constipation (OIC) Treatment market in Chapter 13.

    By Player:

    • AstraZeneca plc, Inc

    • SLA Pharma AG

    • GlaxoSmithKline, Inc

    • AIKO Biotechnology

    • Takeda Pharmaceutical Company Limited

    • Pfizer, Inc

    • Cubist Pharmaceuticals

    • Salix Pharmaceuticals, Inc

    By Type:

    • Oral

    • Parenteral (Subcutaneous Injection)

    By End-User:

    • Drug Store

    • Independent Pharmacies

    • Hospital Pharmacies

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Opioid-Induced Constipation (OIC) Treatment Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Opioid-Induced Constipation (OIC) Treatment Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Opioid-Induced Constipation (OIC) Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Opioid-Induced Constipation (OIC) Treatment Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Opioid-Induced Constipation (OIC) Treatment Market Analysis and Outlook to 2022

    • 7.1 Global Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

    • 7.2 United States Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

    • 7.3 Europe Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

    • 7.4 China Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

    • 7.5 Japan Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

    • 7.6 India Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

    • 7.7 South Korea Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

    8 Region and Country-wise Opioid-Induced Constipation (OIC) Treatment Market Analysis and Outlook to 2028

    • 8.1 Global Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

    • 8.2 United States Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

    • 8.3 Europe Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

    • 8.4 China Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

    • 8.5 Japan Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

    • 8.6 India Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

    • 8.7 South Korea Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

    9 Global Opioid-Induced Constipation (OIC) Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Oral Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Parenteral (Subcutaneous Injection) Consumption and Growth Rate (2017-2022)

    • 9.2 Global Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Drug Store Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Independent Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

    10 Global Opioid-Induced Constipation (OIC) Treatment Market Outlook by Types and Applications to 2028

    • 10.1 Global Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Oral Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Parenteral (Subcutaneous Injection) Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Drug Store Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Independent Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    11 Global Opioid-Induced Constipation (OIC) Treatment Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Opioid-Induced Constipation (OIC) Treatment Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Opioid-Induced Constipation (OIC) Treatment Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Opioid-Induced Constipation (OIC) Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Opioid-Induced Constipation (OIC) Treatment Market Competitive Analysis

    • 14.1 AstraZeneca plc, Inc

      • 14.1.1 AstraZeneca plc, Inc Company Details

      • 14.1.2 AstraZeneca plc, Inc Opioid-Induced Constipation (OIC) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 AstraZeneca plc, Inc Opioid-Induced Constipation (OIC) Treatment Product and Service

    • 14.2 SLA Pharma AG

      • 14.2.1 SLA Pharma AG Company Details

      • 14.2.2 SLA Pharma AG Opioid-Induced Constipation (OIC) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 SLA Pharma AG Opioid-Induced Constipation (OIC) Treatment Product and Service

    • 14.3 GlaxoSmithKline, Inc

      • 14.3.1 GlaxoSmithKline, Inc Company Details

      • 14.3.2 GlaxoSmithKline, Inc Opioid-Induced Constipation (OIC) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 GlaxoSmithKline, Inc Opioid-Induced Constipation (OIC) Treatment Product and Service

    • 14.4 AIKO Biotechnology

      • 14.4.1 AIKO Biotechnology Company Details

      • 14.4.2 AIKO Biotechnology Opioid-Induced Constipation (OIC) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 AIKO Biotechnology Opioid-Induced Constipation (OIC) Treatment Product and Service

    • 14.5 Takeda Pharmaceutical Company Limited

      • 14.5.1 Takeda Pharmaceutical Company Limited Company Details

      • 14.5.2 Takeda Pharmaceutical Company Limited Opioid-Induced Constipation (OIC) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Takeda Pharmaceutical Company Limited Opioid-Induced Constipation (OIC) Treatment Product and Service

    • 14.6 Pfizer, Inc

      • 14.6.1 Pfizer, Inc Company Details

      • 14.6.2 Pfizer, Inc Opioid-Induced Constipation (OIC) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Pfizer, Inc Opioid-Induced Constipation (OIC) Treatment Product and Service

    • 14.7 Cubist Pharmaceuticals

      • 14.7.1 Cubist Pharmaceuticals Company Details

      • 14.7.2 Cubist Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Cubist Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Product and Service

    • 14.8 Salix Pharmaceuticals, Inc

      • 14.8.1 Salix Pharmaceuticals, Inc Company Details

      • 14.8.2 Salix Pharmaceuticals, Inc Opioid-Induced Constipation (OIC) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Salix Pharmaceuticals, Inc Opioid-Induced Constipation (OIC) Treatment Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Opioid-Induced Constipation (OIC) Treatment

    • Figure Opioid-Induced Constipation (OIC) Treatment Picture

    • Table Global Opioid-Induced Constipation (OIC) Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Opioid-Induced Constipation (OIC) Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Opioid-Induced Constipation (OIC) Treatment Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Opioid-Induced Constipation (OIC) Treatment Consumption by Country (2017-2022)

    • Figure United States Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure China Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Opioid-Induced Constipation (OIC) Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oral Consumption and Growth Rate (2017-2022)

    • Figure Global Parenteral (Subcutaneous Injection) Consumption and Growth Rate (2017-2022)

    • Figure Global Drug Store Consumption and Growth Rate (2017-2022)

    • Figure Global Independent Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Parenteral (Subcutaneous Injection) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Drug Store Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Independent Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Opioid-Induced Constipation (OIC) Treatment Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Opioid-Induced Constipation (OIC) Treatment Export by Region (Top 5 Countries) (2017-2028)

    • Table AstraZeneca plc, Inc (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca plc, Inc Opioid-Induced Constipation (OIC) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca plc, Inc Opioid-Induced Constipation (OIC) Treatment Product and Service

    • Table SLA Pharma AG (Foundation Year, Company Profile and etc.)

    • Table SLA Pharma AG Opioid-Induced Constipation (OIC) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table SLA Pharma AG Opioid-Induced Constipation (OIC) Treatment Product and Service

    • Table GlaxoSmithKline, Inc (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline, Inc Opioid-Induced Constipation (OIC) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline, Inc Opioid-Induced Constipation (OIC) Treatment Product and Service

    • Table AIKO Biotechnology (Foundation Year, Company Profile and etc.)

    • Table AIKO Biotechnology Opioid-Induced Constipation (OIC) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table AIKO Biotechnology Opioid-Induced Constipation (OIC) Treatment Product and Service

    • Table Takeda Pharmaceutical Company Limited (Foundation Year, Company Profile and etc.)

    • Table Takeda Pharmaceutical Company Limited Opioid-Induced Constipation (OIC) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takeda Pharmaceutical Company Limited Opioid-Induced Constipation (OIC) Treatment Product and Service

    • Table Pfizer, Inc (Foundation Year, Company Profile and etc.)

    • Table Pfizer, Inc Opioid-Induced Constipation (OIC) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer, Inc Opioid-Induced Constipation (OIC) Treatment Product and Service

    • Table Cubist Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Cubist Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cubist Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Product and Service

    • Table Salix Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Salix Pharmaceuticals, Inc Opioid-Induced Constipation (OIC) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Salix Pharmaceuticals, Inc Opioid-Induced Constipation (OIC) Treatment Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US